Gc Biopharma — FY2023 Earnings Presentation

5 slides from Gc Biopharma's earnings presentation, Jan 31, 2024

Slide 1: Financial Results in 2023
<> GCBiopharma | Financial Results in 2023
Slide 2: Revenue by GC Biopharma and subsidiaries
1,711.3 81.3 1,626.6 Subsidiaries 466.4 416.8 34.4 GC Biopharma 1,244.9 1,209.8 2022 2023 2024 2022 2023 2024
Slide 3: 432.9 439.4 232.4 233.5 411.5 405.0 70.9 349.5 57.4
432.9 439.4 232.4 233.5 411.5 405.0 70.9 349.5 57.4
Slide 4: [Back-up] Income Statement (Summary)
> GCBiopharma [Back-up] Income Statement(Summary) (Unit: KRW Billion) . Quarterly Annually Consolidated 3023 4022 QoQ(%) YoY (%) FY2022 YoY (%) Revenue 439.4 as (7.9) (1.6) 471.3 (6.0) Gross Profit 140.9 125.4 (26.5) (17.5) 581.8 (16.7) SGRA+R&D 108.1 147.8 35 (24.3) 500.5 (10.1) Operating Profit 32
Slide 5: [Back-up] Balance Sheet
[Back-up] Balance Sheet > GCBiopharma Consolidated Unconsolidated (Unit: KRW Billion) (Unit: KRW Billion) 2023 ; 2022 202214 Total Assets 2,643.3 2,525.5 Total Assets 2,101.3 1,943.2 Current Assets Ys 980.4 Current Assets Wig 758.8 Cash and Cash Equivalents { 49.7 105.4 Cash and Cash Equivalents 17.